Cargill’s EpiCor postbiotic reduces inflammatory immune markers within hours, trial finds
Newly published research supports the immune-boosting benefits of a single dose of Cargill’s yeast-derived postbiotic EpiCor. Scientists have found the ingredient rapidly modulates inflammatory cytokines and immune surveillance markers in thirty healthy adults. The findings build on a growing body of evidence, including pediatric literature detailing how the ingredient helps reduce cold and flu symptoms in children aged four to 12.This Technical Paper is brought to you by Lallemand Bio-Ingredients.
Mónica Gómez Navarro, marketing manager of Branded Ingredients at Bioiberica, shares how functional ingredients support long-term wellness. She details how Bioiberica’s Mobilee targets joint mobility and muscle health for active seniors, Dermial and Collavant n2’s support for skin health over time, and how DAOgest connects gut health to broader healthy aging goals, offering brands a range of multibenefit solutions.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Smart sugar control Aug 2026

Advanced immune supportAug 2026
Multimedia
Mónica Gómez Navarro, marketing manager of Branded Ingredients at Bioiberica, shares how functional ingredients support long-term wellness. She details how Bioiberica’s Mobilee targets joint mobility and muscle health for active seniors, Dermial and Collavant n2’s support for skin health over...
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa
































